Filing Flows › Xenetic Biosciences (XBIO) › Q1 2026 › vs Q1 2025
Xenetic Biosciences (XBIO) Q1 2026 vs Q1 2025 (year over year)
Xenetic Biosciences's revenue rose $214K (+36%) from $593K in Q1 2025 to $807K in Q1 2026.
Xenetic Biosciences, Q1 2026: revenue $807K (+36% year over year), operating margin -62.2%, net loss $456K, operating cash flow −$536K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $807K | $593K | $214K | +36% |
| Other income, net | $46K | $39K | $6K | +16% |
| Net loss | $456K | $903K | −$447K | -49% |
| Costs & expenses | $1.3M | $1.5M | −$227K | -15% |
| Operating costs | $1.3M | $1.5M | −$227K | -15% |
| Research & development | $661K | $879K | −$218K | -25% |
| General & admin | $648K | $657K | −$9K | -1% |
| Operating cash sources | $548K | $1.0M | −$473K | -46% |
| Share-based compensation | $11K | $19K | −$8K | -41% |
| Cash used in operations | $536K | $1.0M | −$466K | -46% |
| Net loss absorbed | $456K | $903K | −$447K | -49% |
| Working capital & other | $91K | $118K | −$27K | -23% |
Questions
How much did Xenetic Biosciences's revenue grow year over year in Q1 2026?
Xenetic Biosciences's revenue rose $214K (+36%) from $593K in Q1 2025 to $807K in Q1 2026.